83 related articles for article (PubMed ID: 1776267)
21. Metabolism of albendazole and albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle.
Lanusse CE; Nare B; Gascon LH; Prichard RK
Xenobiotica; 1992 Apr; 22(4):419-26. PubMed ID: 1523862
[TBL] [Abstract][Full Text] [Related]
22. Time dependent pharmacokinetics of albendazole in human.
Mirfazaelian A; Rouini MR; Dadashzadeh S
Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics in sheep and cattle of albendazole administered by an intraruminal slow release capsule.
Delatour P; Benoit E; Lechenet J; Besse S
Res Vet Sci; 1990 May; 48(3):271-5. PubMed ID: 2359877
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the disposition of albendazole metabolites in sheep.
Cristòfol C; Navarro M; Franquelo C; Valladares JE; Arboix M
Vet Parasitol; 1998 Aug; 78(3):223-31. PubMed ID: 9760064
[TBL] [Abstract][Full Text] [Related]
25. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
[TBL] [Abstract][Full Text] [Related]
26. Enantioselective liver microsomal sulphoxidation of albendazole in cattle: effect of nutritional status.
Virkel G; Lifschitz A; Soraci A; Sansinanea A; Lanusse C
Xenobiotica; 2000 Apr; 30(4):381-93. PubMed ID: 10821167
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a commercially available enzyme-linked immunosorbent assay for detecting antibodies to Fasciola hepatica and Fasciola gigantica in cattle, sheep and buffaloes in Australia.
Molloy JB; Anderson GR; Fletcher TI; Landmann J; Knight BC
Vet Parasitol; 2005 Jun; 130(3-4):207-12. PubMed ID: 15925723
[TBL] [Abstract][Full Text] [Related]
28. Albendazole as a fasciolicide in experimentally infected sheep.
Knight RA; Colglazier ML
Am J Vet Res; 1977 Jun; 38(6):807-8. PubMed ID: 879579
[TBL] [Abstract][Full Text] [Related]
29. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.
Moroni P; Buronfosse T; Longin-Sauvageon C; Delatour P; Benoit E
Drug Metab Dispos; 1995 Feb; 23(2):160-5. PubMed ID: 7736906
[TBL] [Abstract][Full Text] [Related]
30. The effect of route of infection on acquired resistance to Fasciola hepatica in the rat and sheep.
Kelly JD; Campbell NJ
Res Vet Sci; 1979 Sep; 27(2):205-9. PubMed ID: 523806
[TBL] [Abstract][Full Text] [Related]
31. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.
Delatour P; Garnier F; Benoit E; Caude I
Res Vet Sci; 1991 Mar; 50(2):134-8. PubMed ID: 2034891
[TBL] [Abstract][Full Text] [Related]
32. Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).
Cvilink V; Szotáková B; Krízová V; Lamka J; Skálová L
Res Vet Sci; 2009 Feb; 86(1):49-55. PubMed ID: 18565554
[TBL] [Abstract][Full Text] [Related]
33. The resistance of sheep to Fasciola hepatica: studies on the pathophysiology of challenge infections.
Sinclair KB
Res Vet Sci; 1975 Nov; 19(3):296-303. PubMed ID: 1061964
[TBL] [Abstract][Full Text] [Related]
34. Flukicidal action of closantel against immature and mature Fasciola hepatica in experimentally infected rats and sheep.
Maes L; Lauwers H; Deckers W; Vanparijs O
Res Vet Sci; 1988 Mar; 44(2):229-32. PubMed ID: 3387677
[TBL] [Abstract][Full Text] [Related]
35. Myocastor coypus as a reservoir host of Fasciola hepatica in France.
Ménard A; Agoulon A; L'Hostis ML; Rondelaud D; Collard S; Chauvin A
Vet Res; 2001; 32(5):499-508. PubMed ID: 11592619
[TBL] [Abstract][Full Text] [Related]
36. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
38. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of pharmacokinetic interactions between piperonyl butoxide and albendazole against gastrointestinal nematodiasis in goats.
Kumbhakar NK; Sanyal PK; Rawte D; Kumar D; Kerketta AE; Pal S
J Helminthol; 2016 Sep; 90(5):624-9. PubMed ID: 26566193
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of Fasciola hepatica infections in sheep by an enzyme-linked immunosorbent assay.
Zimmerman GL; Jen LW; Cerro JE; Farnsworth KL; Wescott RB
Am J Vet Res; 1982 Dec; 43(12):2097-100. PubMed ID: 7165155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
